HEADER SIGNALING PROTEIN 06-NOV-20 7AVX TITLE MERTK KINASE DOMAIN IN COMPLEX WITH NPS-1034 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (571-864); COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER,RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MERTK, MER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TYROSINE KINASE, INHIBITOR, TYPE1.5 KINASE INHIBITOR, TYPE2 KINASE KEYWDS 2 INHIBITOR, STRUCTURE-BASED DRUG DESIGN, ONCOLOGY, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,J.W.M.NISSINK,C.BLACKETT,K.GOLDBERG,E.J.HENNESSY, AUTHOR 2 E.HARDAKER,W.MCCOULL,L.MCMURRAY,O.COLLINGWOOD,R.OVERMAN,A.PFLUG, AUTHOR 3 M.PRESTON,P.RAWLINS,E.RIVERS,P.SMITH,E.UNDERWOOD,C.TRUMAN, AUTHOR 4 J.WARWICKER,J.WINTER,S.WOODCOCK REVDAT 4 01-MAY-24 7AVX 1 REMARK REVDAT 3 07-APR-21 7AVX 1 JRNL REVDAT 2 24-MAR-21 7AVX 1 JRNL REVDAT 1 03-MAR-21 7AVX 0 JRNL AUTH J.W.M.NISSINK,S.BAZZAZ,C.BLACKETT,M.A.CLARK,O.COLLINGWOOD, JRNL AUTH 2 J.S.DISCH,D.GIKUNJU,K.GOLDBERG,J.P.GUILINGER,E.HARDAKER, JRNL AUTH 3 E.J.HENNESSY,R.JETSON,A.D.KEEFE,W.MCCOULL,L.MCMURRAY, JRNL AUTH 4 A.OLSZEWSKI,R.OVERMAN,A.PFLUG,M.PRESTON,P.B.RAWLINS, JRNL AUTH 5 E.RIVERS,M.SCHIMPL,P.SMITH,C.TRUMAN,E.UNDERWOOD,J.WARWICKER, JRNL AUTH 6 J.WINTER-HOLT,S.WOODCOCK,Y.ZHANG JRNL TITL GENERATING SELECTIVE LEADS FOR MER KINASE INHIBITORS-EXAMPLE JRNL TITL 2 OF A COMPREHENSIVE LEAD-GENERATION STRATEGY. JRNL REF J.MED.CHEM. V. 64 3165 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33683117 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01904 REMARK 2 REMARK 2 RESOLUTION. 2.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 24841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.740 REMARK 3 FREE R VALUE TEST SET COUNT : 1178 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.44 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2582 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2761 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2459 REMARK 3 BIN R VALUE (WORKING SET) : 0.2738 REMARK 3 BIN FREE R VALUE : 0.3261 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.76 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 123 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4191 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 97 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.75670 REMARK 3 B22 (A**2) : 2.46180 REMARK 3 B33 (A**2) : 3.29490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -7.14180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.382 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.385 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.259 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.409 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.266 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4416 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6025 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1481 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 88 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 636 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4416 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 559 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5138 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.72 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.51 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 20.5651 -28.7804 5.0665 REMARK 3 T TENSOR REMARK 3 T11: 0.1827 T22: -0.1325 REMARK 3 T33: -0.1521 T12: 0.0258 REMARK 3 T13: 0.0085 T23: -0.0032 REMARK 3 L TENSOR REMARK 3 L11: 1.3137 L22: 1.7654 REMARK 3 L33: 1.5760 L12: 0.3711 REMARK 3 L13: -0.4724 L23: 0.1088 REMARK 3 S TENSOR REMARK 3 S11: -0.0135 S12: 0.1016 S13: 0.0011 REMARK 3 S21: -0.0553 S22: 0.0770 S23: 0.0641 REMARK 3 S31: 0.0138 S32: -0.1285 S33: -0.0635 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.3000 0.7257 25.0966 REMARK 3 T TENSOR REMARK 3 T11: 0.2192 T22: -0.1206 REMARK 3 T33: -0.0871 T12: -0.0094 REMARK 3 T13: 0.0751 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 0.4591 L22: 1.4726 REMARK 3 L33: 1.7163 L12: -0.0419 REMARK 3 L13: -0.1754 L23: -0.4468 REMARK 3 S TENSOR REMARK 3 S11: 0.0056 S12: 0.0108 S13: 0.1072 REMARK 3 S21: 0.0939 S22: 0.0999 S23: 0.1894 REMARK 3 S31: 0.0189 S32: -0.1732 S33: -0.1055 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AVX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25043 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.440 REMARK 200 RESOLUTION RANGE LOW (A) : 54.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.74200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLISATION OF 0.3 MM PROTEIN REMARK 280 WITH 0.5 MM COMPOUND (1 % DMSO) IN 4.0 M SODIUM CHLORIDE, 0.1 M REMARK 280 TRIS PH 8.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.34700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMER REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMER REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 552 REMARK 465 GLY A 553 REMARK 465 SER A 554 REMARK 465 SER A 555 REMARK 465 HIS A 556 REMARK 465 HIS A 557 REMARK 465 HIS A 558 REMARK 465 HIS A 559 REMARK 465 HIS A 560 REMARK 465 HIS A 561 REMARK 465 SER A 562 REMARK 465 SER A 563 REMARK 465 GLY A 564 REMARK 465 LEU A 565 REMARK 465 VAL A 566 REMARK 465 PRO A 567 REMARK 465 ARG A 568 REMARK 465 GLY A 569 REMARK 465 SER A 570 REMARK 465 GLU A 571 REMARK 465 GLU A 572 REMARK 465 LEU A 573 REMARK 465 GLN A 574 REMARK 465 ASN A 575 REMARK 465 LYS A 576 REMARK 465 MET A 659 REMARK 465 SER A 660 REMARK 465 SER A 661 REMARK 465 GLN A 662 REMARK 465 GLY A 663 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ASP A 863 REMARK 465 VAL A 864 REMARK 465 MET B 552 REMARK 465 GLY B 553 REMARK 465 SER B 554 REMARK 465 SER B 555 REMARK 465 HIS B 556 REMARK 465 HIS B 557 REMARK 465 HIS B 558 REMARK 465 HIS B 559 REMARK 465 HIS B 560 REMARK 465 HIS B 561 REMARK 465 SER B 562 REMARK 465 SER B 563 REMARK 465 GLY B 564 REMARK 465 LEU B 565 REMARK 465 VAL B 566 REMARK 465 PRO B 567 REMARK 465 ARG B 568 REMARK 465 GLY B 569 REMARK 465 SER B 570 REMARK 465 GLU B 571 REMARK 465 GLU B 572 REMARK 465 LEU B 573 REMARK 465 GLN B 574 REMARK 465 ASN B 575 REMARK 465 LYS B 576 REMARK 465 ASP B 624 REMARK 465 ASN B 625 REMARK 465 SER B 626 REMARK 465 GLY B 743 REMARK 465 LEU B 744 REMARK 465 SER B 745 REMARK 465 LYS B 746 REMARK 465 LYS B 747 REMARK 465 ILE B 748 REMARK 465 TYR B 749 REMARK 465 SER B 750 REMARK 465 GLY B 751 REMARK 465 ASP B 752 REMARK 465 TYR B 753 REMARK 465 TYR B 754 REMARK 465 ARG B 755 REMARK 465 GLN B 756 REMARK 465 GLY B 757 REMARK 465 ARG B 758 REMARK 465 ILE B 759 REMARK 465 ALA B 760 REMARK 465 LYS B 761 REMARK 465 MET B 762 REMARK 465 ASP B 863 REMARK 465 VAL B 864 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 578 CG CD OE1 OE2 REMARK 470 ASP A 579 CG OD1 OD2 REMARK 470 GLU A 597 CG CD OE1 OE2 REMARK 470 PHE A 598 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 622 CG CD CE NZ REMARK 470 ASP A 624 CG OD1 OD2 REMARK 470 ARG A 629 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 631 CD1 REMARK 470 GLU A 632 CG CD OE1 OE2 REMARK 470 LYS A 666 CG CD CE NZ REMARK 470 LYS A 693 CG CD CE NZ REMARK 470 LYS A 747 CG CD CE NZ REMARK 470 ILE A 748 CG1 CG2 CD1 REMARK 470 ASP A 752 CG OD1 OD2 REMARK 470 ARG A 758 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 775 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 824 CG OD1 OD2 REMARK 470 LEU A 842 CG CD1 CD2 REMARK 470 LYS A 856 CD CE NZ REMARK 470 GLU B 578 CG CD OE1 OE2 REMARK 470 ASP B 579 CG OD1 OD2 REMARK 470 GLU B 597 CG CD OE1 OE2 REMARK 470 PHE B 598 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 609 CG CD OE1 OE2 REMARK 470 LEU B 623 CG CD1 CD2 REMARK 470 GLN B 628 CG CD OE1 NE2 REMARK 470 ARG B 629 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 631 CD1 REMARK 470 GLU B 632 CG CD OE1 OE2 REMARK 470 MET B 641 CG SD CE REMARK 470 GLN B 662 CG CD OE1 NE2 REMARK 470 LYS B 666 CG CD CE NZ REMARK 470 LYS B 693 CG CD CE NZ REMARK 470 ASP B 774 CG OD1 OD2 REMARK 470 ARG B 775 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 824 CG OD1 OD2 REMARK 470 LYS B 856 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 626 32.27 -80.86 REMARK 500 THR A 690 -26.22 93.03 REMARK 500 ASP A 723 33.02 -152.96 REMARK 500 SER A 750 -93.85 28.41 REMARK 500 ILE A 759 -70.67 -59.97 REMARK 500 ASP A 824 70.88 -101.79 REMARK 500 THR B 690 -25.61 93.44 REMARK 500 ASP B 723 34.28 -153.26 REMARK 500 ASP B 741 -166.90 -114.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S4K A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S4K B 901 DBREF 7AVX A 570 864 UNP Q12866 MERTK_HUMAN 570 864 DBREF 7AVX B 570 864 UNP Q12866 MERTK_HUMAN 570 864 SEQADV 7AVX MET A 552 UNP Q12866 INITIATING METHIONINE SEQADV 7AVX GLY A 553 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER A 554 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER A 555 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 556 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 557 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 558 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 559 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 560 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS A 561 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER A 562 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER A 563 UNP Q12866 EXPRESSION TAG SEQADV 7AVX GLY A 564 UNP Q12866 EXPRESSION TAG SEQADV 7AVX LEU A 565 UNP Q12866 EXPRESSION TAG SEQADV 7AVX VAL A 566 UNP Q12866 EXPRESSION TAG SEQADV 7AVX PRO A 567 UNP Q12866 EXPRESSION TAG SEQADV 7AVX ARG A 568 UNP Q12866 EXPRESSION TAG SEQADV 7AVX GLY A 569 UNP Q12866 EXPRESSION TAG SEQADV 7AVX MET B 552 UNP Q12866 INITIATING METHIONINE SEQADV 7AVX GLY B 553 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER B 554 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER B 555 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 556 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 557 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 558 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 559 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 560 UNP Q12866 EXPRESSION TAG SEQADV 7AVX HIS B 561 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER B 562 UNP Q12866 EXPRESSION TAG SEQADV 7AVX SER B 563 UNP Q12866 EXPRESSION TAG SEQADV 7AVX GLY B 564 UNP Q12866 EXPRESSION TAG SEQADV 7AVX LEU B 565 UNP Q12866 EXPRESSION TAG SEQADV 7AVX VAL B 566 UNP Q12866 EXPRESSION TAG SEQADV 7AVX PRO B 567 UNP Q12866 EXPRESSION TAG SEQADV 7AVX ARG B 568 UNP Q12866 EXPRESSION TAG SEQADV 7AVX GLY B 569 UNP Q12866 EXPRESSION TAG SEQRES 1 A 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 A 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 A 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 A 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 A 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 A 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 A 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 A 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 A 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 A 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 A 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 A 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 A 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 A 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 A 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 A 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 A 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 A 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 A 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 A 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 A 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 A 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 A 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 A 313 VAL SEQRES 1 B 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 B 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 B 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 B 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 B 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 B 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 B 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 B 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 B 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 B 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 B 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 B 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 B 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 B 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 B 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 B 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 B 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 B 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 B 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 B 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 B 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 B 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 B 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 B 313 VAL HET S4K A 901 41 HET S4K B 901 41 HETNAM S4K 1-(4-FLUOROPHENYL)-N-[3-FLUORO-4-[(3-PHENYL-1H- HETNAM 2 S4K PYRROLO[2,3-B]PYRIDIN-4-YL)OXY]PHENYL]-2,3-DIMETHYL-5- HETNAM 3 S4K OXOPYRAZOLE-4-CARBOXAMIDE HETSYN S4K ~{N}-[3-FLUORANYL-4-[(3-PHENYL-1~{H}-PYRROLO[2,3- HETSYN 2 S4K B]PYRIDIN-4-YL)OXY]PHENYL]-1-(4-FLUOROPHENYL)-2,3- HETSYN 3 S4K DIMETHYL-5-OXIDANYLIDENE-PYRAZOLE-4-CARBOXAMIDE; N-(3- HETSYN 4 S4K FLUORO-4-((3-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YL) HETSYN 5 S4K OXY)PHENYL)-2-(4-FLUOROPHENYL)-1,5-DIMETHYL-3-OXO-2,3- HETSYN 6 S4K DIHYDRO-1H-PYRAZOLE-4-CARBOXAMIDE FORMUL 3 S4K 2(C31 H23 F2 N5 O3) FORMUL 5 HOH *97(H2 O) HELIX 1 AA1 ASP A 583 ASN A 585 5 3 HELIX 2 AA2 SER A 627 ASP A 643 1 17 HELIX 3 AA3 ASP A 678 SER A 686 1 9 HELIX 4 AA4 PRO A 696 ARG A 717 1 22 HELIX 5 AA5 ALA A 725 ARG A 727 5 3 HELIX 6 AA6 PRO A 763 ILE A 767 5 5 HELIX 7 AA7 ALA A 768 ASP A 774 1 7 HELIX 8 AA8 THR A 778 THR A 795 1 18 HELIX 9 AA9 GLN A 805 HIS A 807 5 3 HELIX 10 AB1 GLU A 808 HIS A 815 1 8 HELIX 11 AB2 LEU A 826 CYS A 836 1 11 HELIX 12 AB3 ASP A 840 ARG A 844 5 5 HELIX 13 AB4 THR A 846 LEU A 861 1 16 HELIX 14 AB5 ASP B 583 ASN B 585 5 3 HELIX 15 AB6 GLN B 628 ASP B 643 1 16 HELIX 16 AB7 ASP B 678 SER B 686 1 9 HELIX 17 AB8 PRO B 696 ARG B 717 1 22 HELIX 18 AB9 ALA B 725 ARG B 727 5 3 HELIX 19 AC1 PRO B 763 ILE B 767 5 5 HELIX 20 AC2 ALA B 768 ASP B 774 1 7 HELIX 21 AC3 THR B 778 THR B 795 1 18 HELIX 22 AC4 GLN B 805 HIS B 807 5 3 HELIX 23 AC5 GLU B 808 HIS B 815 1 8 HELIX 24 AC6 LEU B 826 CYS B 836 1 11 HELIX 25 AC7 ASP B 840 ARG B 844 5 5 HELIX 26 AC8 THR B 846 LEU B 861 1 16 SHEET 1 AA1 5 LEU A 587 GLU A 595 0 SHEET 2 AA1 5 SER A 600 LYS A 607 -1 O VAL A 601 N GLY A 594 SHEET 3 AA1 5 SER A 613 THR A 620 -1 O VAL A 618 N MET A 602 SHEET 4 AA1 5 LYS A 666 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 AA1 5 GLY A 654 GLU A 658 -1 N GLY A 654 O ILE A 670 SHEET 1 AA2 2 CYS A 729 LEU A 731 0 SHEET 2 AA2 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 SHEET 1 AA3 5 LEU B 587 GLU B 595 0 SHEET 2 AA3 5 SER B 600 LYS B 607 -1 O VAL B 601 N GLY B 594 SHEET 3 AA3 5 SER B 613 THR B 620 -1 O VAL B 618 N MET B 602 SHEET 4 AA3 5 PRO B 665 PRO B 672 -1 O LEU B 671 N ALA B 617 SHEET 5 AA3 5 GLY B 654 MET B 659 -1 N GLY B 654 O ILE B 670 SHEET 1 AA4 2 CYS B 729 LEU B 731 0 SHEET 2 AA4 2 VAL B 737 VAL B 739 -1 O CYS B 738 N MET B 730 SITE 1 AC1 20 LEU A 593 VAL A 601 ALA A 617 LYS A 619 SITE 2 AC1 20 MET A 621 PHE A 634 GLU A 637 ALA A 638 SITE 3 AC1 20 MET A 641 ILE A 650 VAL A 669 LEU A 671 SITE 4 AC1 20 PRO A 672 PHE A 673 MET A 674 MET A 730 SITE 5 AC1 20 ALA A 740 ASP A 741 PHE A 742 LEU A 744 SITE 1 AC2 17 LEU B 593 GLY B 594 VAL B 601 ALA B 617 SITE 2 AC2 17 LYS B 619 ILE B 650 VAL B 669 LEU B 671 SITE 3 AC2 17 PRO B 672 PHE B 673 MET B 674 LEU B 714 SITE 4 AC2 17 PHE B 719 MET B 730 ALA B 740 ASP B 741 SITE 5 AC2 17 PHE B 742 CRYST1 55.641 92.694 70.118 90.00 105.91 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017972 0.000000 0.005123 0.00000 SCALE2 0.000000 0.010788 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014830 0.00000